RayzeBio, Inc.
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch RayzeBio, Inc. and buy or sell other stocks, ETFs, and their options commission-free!About RYZB
Rayzebio, Inc. provides radiopharmaceutical medicines for cancer. It develops a pipeline against validated oncology drug targets to deliver radioisotopes that emit alpha particles such as Actinium-225.
CEOKenneth Song, MD
CEOKenneth Song, MD
Employees—
Employees—
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2020
Founded2020
Employees—
Employees—
RYZB Key Statistics
Market cap3.74B
Market cap3.74B
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume44.41K
Average volume44.41K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$62.51
52 Week high$62.51
52 Week low$17.95
52 Week low$17.95
Stock Snapshot
With a market cap of 3.74B, RayzeBio, Inc.(RYZB) trades at $62.49.
During the trading day, RayzeBio, Inc.(RYZB) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading activity shows a volume of 0, compared to an average daily volume of 44.41K.
The stock's 52-week range extends from a low of $17.95 to a high of $62.51.
The stock's 52-week range extends from a low of $17.95 to a high of $62.51.
People also own
Based on the portfolios of people who own RYZB. This list is generated using Robinhood data, and it’s not a recommendation.
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.